5310W-12 Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy

Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

Type of Study
Heart & Vascular
Short Description

To compare the safety and efficacy of bridging anticoagulation with not bridging anticoagulation on the rate of major bleeding in patients who require temporary interruption of warfarin.

Status
Open
Principal Investigator
John Petersen II, MD
Eligibility Notes

Patients, 18 or older, with atrial fibrillation or atrial flutter who are receiving longterm warfarin therapy and require temporary interruption of warfarin because of an elective surgical or other invasive procedure.

Contact Name
Jennifer Nagel or Deborah Tinlin, RN
Phone
206-386-6462
Alternate Phone
206-215-2455
Email
jennifer.nagel@swedish.org
Alternate Email
deborah.tinlin@swedish.org